Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance-Reference-Cited by-同舟云学术

Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance

Published:2009-05-15 Issue:10 Volume:15 Page:3484-3494
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Naumov George N.,Nilsson Monique B.,Cascone Tina,Briggs Alexandra,Straume Oddbjorn,Akslen Lars A.,Lifshits Eugene,Byers Lauren Averett,Xu Li,Wu Hua-kang,Jänne Pasi,Kobayashi Susumu,Halmos Balazs,Tenen Daniel,Tang Xi M.,Engelman Jeffrey,Yeap Beow,Folkman Judah,Johnson Bruce E.,Heymach John V.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 305 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toxicity profiles associated with EGFR-TKIs combined with angiogenesis inhibitors in non-small cell lung cancer: an epidemiological surveillance analysis of the FDA adverse event reporting system;Expert Opinion on Drug Safety;2024-09-11

2. Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma;Modern Pathology;2024-09

3. Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategies;MedComm;2024-08-24

4. FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies;Cancer Communications;2024-08-19

5. Adaptive resistance of tumor cells to anti-vascular endothelial growth factor therapy: A reversible phenomenon;Cytokine;2024-08